Drug recall · October 23, 2024
Cisplatin Injection recall
Why: Failed Impurities/Degradation Specifications.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: Accord Healthcare Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad 382 213, India. Mfg. Lic. No.: G/28/1336, NDC 16729-288-38
- Lots / codes
Lot #: P2202009, Exp. Date: 03/2025
- Quantity
- 11,214 vials
- Company
- Accord Healthcare, Inc., Raleigh, NC
- Distribution
- Nationwide within the United States and PR
- Initiated
- October 1, 2024 · Voluntary: Firm initiated
- Classified
- October 11, 2024
- Reported
- October 23, 2024
- Ended
- February 23, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cisplatin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.